0001209191-16-138845.txt : 20160826 0001209191-16-138845.hdr.sgml : 20160826 20160826183851 ACCESSION NUMBER: 0001209191-16-138845 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160825 FILED AS OF DATE: 20160826 DATE AS OF CHANGE: 20160826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kite Pharma, Inc. CENTRAL INDEX KEY: 0001510580 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 2225 COLORADO AVENUE CITY: SANTA MONICA STATE: CA ZIP: 90404 BUSINESS PHONE: (310) 824-9999 MAIL ADDRESS: STREET 1: 2225 COLORADO AVENUE CITY: SANTA MONICA STATE: CA ZIP: 90404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUTITTA CYNTHIA M CENTRAL INDEX KEY: 0001222082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36508 FILM NUMBER: 161855812 MAIL ADDRESS: STREET 1: 3165 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-25 0 0001510580 Kite Pharma, Inc. KITE 0001222082 BUTITTA CYNTHIA M C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404 0 1 0 0 Chief Operating Officer Common Stock 2016-08-25 4 M 0 10000 1.35 A 105477 D Common Stock 2016-08-25 4 S 0 7500 58.03 D 97977 D Common Stock 2016-08-25 4 S 0 2500 59.02 D 95477 D Employee Stock Option (Right to Buy) 1.35 2016-08-25 4 M 0 10000 0.00 D 2024-03-25 Common Stock 10000 265394 D Includes 76 shares acquired under the 2014 Employee Stock Purchase Plan on August 19, 2016. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.40 to $58.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.57 to $59.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. 108,839 of the 435,394 shares originally subject to the stock option vested and became exercisable on December 15, 2014, and 9,071 shares vest monthly thereafter. /s/ David M. Tanen, Attorney-in-Fact 2016-08-26